The 10th Annual Meeting of the Myocardial and Pericardial diseases Working Group held in Prague from October 24 to 26, 2013 has had an educational and scientific mission summarized by the phrase: “Bridging the gap”. The gap was intended between recent advances in the etiopathogenetic knowledge on myocardial and pericardial diseases from genetics, immunology, virology and other fields in basic medical sciences and clinical cardiology. As a matter of fact, translational medicine is a feature of the cardiological community with a special interest in myocardial and pericardial diseases that gathers each year during the annual congress of this small but very active ESC working group. The meeting has been attended by 240 colleagues from many European and non-European countries. The highest scored submitted abstracts have been included for oral presentation during main oral sessions to provide higher visibility and involvement to new original contributions in the pertinent field.In the morning of the first day 5 workshops have been presented on different aspects of myopericardial diseases (Wo 1: Clinical genetics in cardiomyopathies, Wo 2: The clinical and diagnostic challenge of myocarditis, Wo 3: Molecular genetics and cardiomyopathies with a joined session with the cardiomyopathies with a joined session with the European Society of Human Genetics, Wo 4: Heart Failure and Exercise Cardiopulmonary Testing, and Wo 5 on Pericardial Diseases).
Additional joined sessions included the imaging of cardiomyopathies (joint session with the European Association of Cardiovascular Imaging), management of arrhythmias in cardiomyopathies (joint session with the EHRA, CKS, DGK), and metabolic and other pediatric cardiomyopathies (joint session with the European Association of Pediatric Cardiology). Specific session on cardiomyopathies have also included a focus session on Fabry Disease, new insight in the pathophysiology, diagnosis, and treatment of hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia, pregnancy and cardiomyopathies, hypertrophic cardiomyopathy and athlete heart, and a pro and contra session on pre-participation screening for athletes.
In the year 2013 our WG has published 2 very important Position Papers, in the European Heart Journal one entitled: “Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis.”, and another entitled “Current state of knowledge on aetiology, diagnosis, management and therapy of myocarditis.” Both Position papers have inspired several sessions at the Annual Congress in Prague, in keeping with a strong educational commitment of the WG towards cardiologists and internists, geneticists, basic and clinical scientists who work in the multidisciplinary field of myocardial and pericardial diseases. In particular, an interactive Workshop held on the first day was entitled to “The clinical and diagnostic challenge of myocarditis”, covering all the major clinical e diagnostic issues in this poorly understood cardiac condition, in keeping with the new WG Position Statement, that actually represents the first European expert consensus document and the first consensus document in the world literature entirely dedicated to myocarditis. In the plenary sessions, on the last day 2 ordinary symposia one entitled “Inflammatory infectious and non-infectious cardiomyopathies”, another on “Myocarditis” and a Featured Lecture on “Sarcoidosis” were also held.
An additional position paper is under revision for publication in the European Heart Journal, including a score for the triage of cardiac tamponade. Highlights have been presented in the meeting with teaching movies on how to perform fluoroscopy and echocardiography guided pericardiocentesis. For pericardial diseases additional sessions included the contemporary management of pericardial effusion and new advances in the field after the publication of the 2004 ESC guidelines highlighting the need for an update.
Philippe Charron, WG ChairpersonMassimo Imazio, Web editorAles Linhart, Congress Chairperson
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved